XOMA Royalty Corporation (XOMA) Dividend History

Company News

• $HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Turnstone Biologics Corp. (NASDAQ: TSBX)

  Class action attorney Juan Monteverde is investigating the merger of Turnstone Biologics Corp. with XOMA Royalty Corporation, where shareholders will receive $0.34 in cash per share and a contingent value right.

  GlobeNewswire Inc.

  Featured Companies: TSBX XOMAO XOMAP
• XOMA Royalty Declares Quarterly Preferred Stock Dividends

  XOMA Royalty Corporation announced that its Board of Directors has authorized cash dividends for its Series A and Series B Cumulative Preferred Stock. The dividends will be paid on July 15, 2025, to respective holders of record at the close of business on July 3, 2025.

  Benzinga

  Featured Companies: XOMAO XOMAP
• XOMA Corp to rebrand as XOMA Royalty Corporation By Investing.com - Investing.com

  XOMA Corporation, a biotechnology company, announced that it will change its name to XOMA Royalty Corporation, effective July 10, 2024. The rebranding reflects the company's focus on pharmaceutical royalties.

  Investing.com

  Featured Companies: XOMAO XOMAP
• XOMA Corporation: A Hold Rating With Steady Income From Preferred Shares

  XOMA Corporation operates as a biotechnology royalty aggregator, acquiring economic rights to milestones and royalties from approved or clinical-stage drugs.

  Seeking Alpha

  Featured Companies: XOMAO XOMAP
• Xoma (XOMA) Soars 15.6%: Is Further Upside Left in the Stock?

  Xoma (XOMA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

  Zacks Investment Research

  Featured Companies: CUE